Literature DB >> 9159128

Conditional activation defect of a human Gsalpha mutant.

T Iiri1, Z Farfel, H R Bourne.   

Abstract

Hormonal signals activate trimeric G proteins by promoting exchange of GTP for GDP bound to the G protein's alpha subunit (Galpha). Here we describe a point mutation that impairs this activation mechanism in the alpha subunit of Gs, producing an inherited disorder of hormone responsiveness. Biochemical analysis reveals an activation defect that is paradoxically intensified by hormonal and other stimuli. By substituting histidine for a conserved arginine residue, the mutation removes an internal salt bridge (to a conserved glutamate) that normally acts as an intramolecular hasp to maintain tight binding of the gamma-phosphate of GTP. In its basal, unperturbed state, the mutant alphas binds guanosine 5'-[gamma-thio]triphosphate (GTP[gammaS]), a GTP analog, slightly less tightly than does normal alphas, but (in the GTP[gammaS]-bound form) can stimulate adenylyl cyclase. The activation defect becomes prominent only under conditions that destabilize binding of guanine nucleotide (receptor stimulation) or impair the ability of alphas to bind the gamma-phosphate of GTP (cholera toxin, AlF4- ion). Although GDP release is usually the rate-limiting step in nucleotide exchange, the biochemical phenotype of this mutant alphas indicates that efficient G protein activation by receptors and other stimuli depends on the ability of Galpha to clasp tightly the GTP molecule that enters the binding site.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9159128      PMCID: PMC20834          DOI: 10.1073/pnas.94.11.5656

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

Review 1.  Receptor-effector coupling by G proteins: implications for normal and abnormal signal transduction.

Authors:  A M Spiegel; A Shenker; L S Weinstein
Journal:  Endocr Rev       Date:  1992-08       Impact factor: 19.871

2.  Deficient activity of guanine nucleotide regulatory protein in erythrocytes from patients with pseudohypoparathyroidism.

Authors:  M A Levine; R W Downs; M Singer; S J Marx; G D Aurbach; A M Spiegel
Journal:  Biochem Biophys Res Commun       Date:  1980-06-30       Impact factor: 3.575

Review 3.  Structural elements of G alpha subunits that interact with G beta gamma, receptors, and effectors.

Authors:  B R Conklin; H R Bourne
Journal:  Cell       Date:  1993-05-21       Impact factor: 41.582

4.  Purification from Sf9 cells and characterization of recombinant Gq alpha and G11 alpha. Activation of purified phospholipase C isozymes by G alpha subunits.

Authors:  J R Hepler; T Kozasa; A V Smrcka; M I Simon; S G Rhee; P C Sternweis; A G Gilman
Journal:  J Biol Chem       Date:  1993-07-05       Impact factor: 5.157

5.  Hormone-sensitive adenylate cyclase. Mutant phenotype with normally regulated beta-adrenergic receptors uncoupled with catalytic adenylate cyclase.

Authors:  H R Bourne; D Kaslow; H R Kaslow; M R Salomon; V Licko
Journal:  Mol Pharmacol       Date:  1981-09       Impact factor: 4.436

6.  Pseudohypoparathyroidism: inheritance of deficient receptor-cyclase coupling activity.

Authors:  Z Farfel; V M Brothers; A S Brickman; F Conte; R Neer; H R Bourne
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

Review 7.  Pseudohypoparathyroidism: mutation affecting adenylate cyclase.

Authors:  Z Farfel; H R Bourne
Journal:  Miner Electrolyte Metab       Date:  1982 Sep-Oct

8.  Defect of receptor-cyclase coupling protein in psudohypoparathyroidism.

Authors:  Z Farfel; A S Brickman; H R Kaslow; V M Brothers; H R Bourne
Journal:  N Engl J Med       Date:  1980-07-31       Impact factor: 91.245

9.  Catecholamine-induced release of [3H]-Gpp(NH)p from turkey erythrocyte adenylate cyclase.

Authors:  D Cassel; Z Selinger
Journal:  J Cyclic Nucleotide Res       Date:  1977-02

10.  Activation of the alpha subunit of Gs in intact cells alters its abundance, rate of degradation, and membrane avidity.

Authors:  M J Levis; H R Bourne
Journal:  J Cell Biol       Date:  1992-12       Impact factor: 10.539

View more
  14 in total

1.  V2 vasopressin receptor (V2R) mutations in partial nephrogenic diabetes insipidus highlight protean agonism of V2R antagonists.

Authors:  Kazuhiro Takahashi; Noriko Makita; Katsunori Manaka; Masataka Hisano; Yuko Akioka; Kenichiro Miura; Noriyuki Takubo; Atsuko Iida; Norishi Ueda; Makiko Hashimoto; Toshiro Fujita; Takashi Igarashi; Takashi Sekine; Taroh Iiri
Journal:  J Biol Chem       Date:  2011-12-05       Impact factor: 5.157

2.  Regulation of RhoA signaling by the cAMP-dependent phosphorylation of RhoGDIα.

Authors:  Atsuro Oishi; Noriko Makita; Junichiro Sato; Taroh Iiri
Journal:  J Biol Chem       Date:  2012-09-25       Impact factor: 5.157

3.  Disease-Causing Mutations in the G Protein Gαs Subvert the Roles of GDP and GTP.

Authors:  Qi Hu; Kevan M Shokat
Journal:  Cell       Date:  2018-04-05       Impact factor: 41.582

4.  A Gsalpha mutant designed to inhibit receptor signaling through Gs.

Authors:  T Iiri; S M Bell; T J Baranski; T Fujita; H R Bourne
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

5.  Different biochemical properties explain why two equivalent Gα subunit mutants cause unrelated diseases.

Authors:  Anthony Leyme; Arthur Marivin; Jason Casler; Lien T Nguyen; Mikel Garcia-Marcos
Journal:  J Biol Chem       Date:  2014-06-30       Impact factor: 5.157

6.  An acquired hypocalciuric hypercalcemia autoantibody induces allosteric transition among active human Ca-sensing receptor conformations.

Authors:  Noriko Makita; Junichiro Sato; Katsunori Manaka; Yuki Shoji; Atsuro Oishi; Makiko Hashimoto; Toshiro Fujita; Taroh Iiri
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-19       Impact factor: 11.205

7.  Analysis of the V2 Vasopressin Receptor (V2R) Mutations Causing Partial Nephrogenic Diabetes Insipidus Highlights a Sustainable Signaling by a Non-peptide V2R Agonist.

Authors:  Noriko Makita; Tomohiko Sato; Yuki Yajima-Shoji; Junichiro Sato; Katsunori Manaka; Makiko Eda-Hashimoto; Masanori Ootaki; Naoki Matsumoto; Masaomi Nangaku; Taroh Iiri
Journal:  J Biol Chem       Date:  2016-09-06       Impact factor: 5.157

8.  Human G(salpha) mutant causes pseudohypoparathyroidism type Ia/neonatal diarrhea, a potential cell-specific role of the palmitoylation cycle.

Authors:  Noriko Makita; Junichiro Sato; Philippe Rondard; Hiroshi Fukamachi; Yasuhito Yuasa; Micheala A Aldred; Makiko Hashimoto; Toshiro Fujita; Taroh Iiri
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-25       Impact factor: 11.205

Review 9.  Studies of the regulation and function of the Gs alpha gene Gnas using gene targeting technology.

Authors:  Lee S Weinstein; Tao Xie; Qing-Hong Zhang; Min Chen
Journal:  Pharmacol Ther       Date:  2007-04-21       Impact factor: 12.310

10.  A universal allosteric mechanism for G protein activation.

Authors:  Kevin M Knight; Soumadwip Ghosh; Sharon L Campbell; Tyler J Lefevre; Reid H J Olsen; Alan V Smrcka; Natalie H Valentin; Guowei Yin; Nagarajan Vaidehi; Henrik G Dohlman
Journal:  Mol Cell       Date:  2021-02-25       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.